Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davood Bashash

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
The International Journal of Biochemistry & Cell Biology|March 4, 2017
Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to IdelalisibDavood Bashash, Ava Safaroghli-Azar, Maryam Dadashi, et al.
Immunologic Research|February 7, 2020
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancersBahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh, et al.
BMC Urology|April 20, 2021
Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCRReza Yahyazadeh, Davood Bashash, Parisa Ghaffari, et al.
Molecular Biology Reports|October 24, 2021
Small molecules with huge impacts: the role of miRNA-regulated PI3K pathway in human malignanciesBahareh Kashani, Zahra Zandi, Vahid Kaveh, et al.
Anti-Cancer Drugs|February 2, 2018
Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitantSamaneh Bayati, Elham Razani, Davood Bashash, et al.
Journal of Cellular and Molecular Medicine|December 18, 2020
Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesisYazdan Mokhtari, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, et al.
The International Journal of Biochemistry & Cell Biology|August 24, 2017
Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120Davood Bashash, Mahda Delshad, Ava Safaroghli-Azar, et al.
The International Journal of Biochemistry & Cell Biology|September 8, 2016
Inhibitor of pan class-I PI3K induces differentially apoptotic pathways in acute leukemia cells: Shedding new light on NVP-BKM120 mechanism of actionDavood Bashash, Ava Safaroghli-Azar, Mahda Delshad, et al.
Journal of Cellular Physiology|September 9, 2021
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunitiesDavood Bashash, Zahra Zandi, Bahareh Kashani, et al.
Cell Biochemistry and Function|September 16, 2022
An overview of long noncoding RNAs: Biology, functions, therapeutics, analysis methods, and bioinformatics toolsFarideh Jafari-Raddani, Zeinab Davoodi-Moghaddam, Amir-Mohammad Yousefi, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
The International Journal of Biochemistry & Cell Biology|March 4, 2017
Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to IdelalisibDavood Bashash, Ava Safaroghli-Azar, Maryam Dadashi, et al.
Immunologic Research|February 7, 2020
Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancersBahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh, et al.
BMC Urology|April 20, 2021
Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCRReza Yahyazadeh, Davood Bashash, Parisa Ghaffari, et al.
Molecular Biology Reports|October 24, 2021
Small molecules with huge impacts: the role of miRNA-regulated PI3K pathway in human malignanciesBahareh Kashani, Zahra Zandi, Vahid Kaveh, et al.
Anti-Cancer Drugs|February 2, 2018
Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitantSamaneh Bayati, Elham Razani, Davood Bashash, et al.
Journal of Cellular and Molecular Medicine|December 18, 2020
Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesisYazdan Mokhtari, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, et al.
The International Journal of Biochemistry & Cell Biology|August 24, 2017
Novel pan PI3K inhibitor-induced apoptosis in APL cells correlates with suppression of telomerase: An emerging mechanism of action of BKM120Davood Bashash, Mahda Delshad, Ava Safaroghli-Azar, et al.
The International Journal of Biochemistry & Cell Biology|September 8, 2016
Inhibitor of pan class-I PI3K induces differentially apoptotic pathways in acute leukemia cells: Shedding new light on NVP-BKM120 mechanism of actionDavood Bashash, Ava Safaroghli-Azar, Mahda Delshad, et al.
Journal of Cellular Physiology|September 9, 2021
Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunitiesDavood Bashash, Zahra Zandi, Bahareh Kashani, et al.
Cell Biochemistry and Function|September 16, 2022
An overview of long noncoding RNAs: Biology, functions, therapeutics, analysis methods, and bioinformatics toolsFarideh Jafari-Raddani, Zeinab Davoodi-Moghaddam, Amir-Mohammad Yousefi, et al.
Pageof 19